7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Kidney & Urinary Health

How Urethritis Is Diagnosed: Urine Tests, Timing the Sample and What Results Change

24 min read
How Urethritis Is Diagnosed: Urine Tests, Timing the Sample and What Results Change

Key Takeaways

  • The correct urine sample for urethritis testing is first-catch, roughly the initial 20–30 mL of the stream, not the midstream specimen used for bladder infections.
  • CDC guidelines confirm urethritis by visible discharge, two or more white cells per oil-immersion field on Gram stain, or a positive leukocyte esterase or ten or more white cells per high-power field in first-void urine.
  • A urine dipstick can show inflammation but cannot name the organism; a nucleic acid amplification test is required for chlamydia and gonorrhea regardless of the dipstick result.
  • Chlamydia accounts for about 15 to 40 percent of non-gonococcal urethritis and Mycoplasma genitalium for about 15 to 25 percent, and the two need different antibiotic approaches.
  • Testing earlier than about two weeks after exposure can miss chlamydia, so a reassuring early result may need repeating after the window period.
  • After treatment for chlamydia or gonorrhea, the CDC recommends retesting at about three months to catch reinfection, which is far more common than true treatment failure.
Quick Answer

Urethritis is usually diagnosed from a first-catch urine sample, meaning the first part of the stream, tested with a nucleic acid amplification test for chlamydia and gonorrhea, alongside evidence of inflammation such as white cells on microscopy or a positive leukocyte esterase dipstick. A swab of any discharge may be examined under a microscope or cultured. The result guides which antibiotic class is used, which partners are notified and when retesting is advised.

It starts as a sting at the very first second of urinating, a sensation so brief that most people blame dehydration or last night’s drinks. Two mornings later there is a small damp patch in the underwear, and the question changes from “Is this anything?” to “What will they actually do if I go in?”

The honest answer is reassuringly undramatic. Urethritis diagnosis tests revolve around a plastic cup, a few milliliters of urine collected at the right moment, and occasionally a thin swab that takes seconds. The science behind that cup, however, is precise, and the details matter: which part of the stream you catch, how long since you last went, and whether the lab is looking for inflammation, for a specific organism, or for both.

This explainer walks through what happens in the room, what the laboratory does afterward, and why a line on a report can change the antibiotic class, the partner conversation and the follow-up date.

What happens during urethritis diagnosis tests?

Urethritis is inflammation of the urethra, the tube that carries urine from the bladder out of the body. Diagnosing it has two separate jobs: proving that inflammation is present, and finding out what is causing it. Clinicians tackle both in a single visit.

The appointment opens with questions rather than specimens. You will be asked when the burning or discharge began, whether it is worse at the start of the stream, and about recent sexual contact, condom use and any antibiotics taken in the past few weeks. These questions are not judgment; they shape which tests are ordered and how results are interpreted.

Examination follows. In men, the clinician looks for discharge at the tip of the urethra, sometimes after gently pressing along its length, and checks the testicles and groin lymph nodes. In women, the pelvic examination may include inspection of the cervix, because the same organisms that inflame the urethra often inflame the cervix too.

Then come the specimens. The CDC treatment guidelines define urethritis by any one of three findings: visible mucopurulent (cloudy or pus-containing) discharge on examination, two or more white blood cells per oil-immersion field on a Gram stain of urethral secretions, or a positive leukocyte esterase test or ten or more white cells per high-power field in the sediment of first-void urine. Whichever route confirms inflammation, the guidelines also call for a nucleic acid amplification test, a laboratory method that detects the genetic material of chlamydia and gonorrhea, on urine or a swab.

The visit itself rarely takes longer than a routine check-up. The thinking behind it is what separates a precise diagnosis from a guess.

Why the first part of your urine stream matters: timing the sample

Most people have given a midstream urine sample at some point and assume every urine test works the same way. For urethritis, the opposite applies. The organisms and inflammatory cells sit in the urethra itself, so the first few milliliters that flush through it carry the evidence. A midstream sample rinses that evidence down the toilet before the cup is in position.

Female doctor consulting patient holding urine sample cup: Why the first part of your urine stream matters: timing the sampl

The CDC laboratory recommendations for chlamydia and gonorrhea testing describe the ideal specimen as first-catch urine, roughly the initial 20–30 mL of the stream, collected without cleansing the genital area first. Filling the cup is not the goal; catching the beginning is.

Timing since you last urinated is the second detail. Older advice to hold urine for an hour or two originated when laboratories relied on culture, which needs a larger load of living organisms. Modern nucleic acid amplification tests are far more sensitive, and the CDC laboratory guidance notes that these tests perform well on first-catch urine. Many clinics still request a gap of about an hour because it does no harm and keeps the sample concentrated; follow whatever your service asks, and mention it if you urinated minutes before arriving.

A third consideration is the window since exposure. Chlamydia symptoms, when they appear at all, typically start one to three weeks after contact, and NHS guidance suggests testing about two weeks after possible exposure for a reliable result. Gonorrhea symptoms usually surface within two weeks. Someone tested the morning after unprotected sex may be told the result is reassuring for now but that a repeat test after the window is sensible.

Recent antibiotics, even a course taken for an unrelated chest infection, can suppress organisms enough to blunt a culture result. Tell the clinician; it changes how a negative is read.

Can urinalysis detect urethritis?

Partly, and that qualifier is the whole story. A standard urinalysis, the dipstick-and-microscope test used for suspected bladder infections, can reveal inflammation but cannot say what is causing it.

The dipstick has two pads that matter here. Leukocyte esterase is an enzyme released by white blood cells, so a positive pad signals that white cells are present somewhere in the urinary tract. Nitrite appears when certain bacteria, typically the gut organisms behind bladder infections, convert dietary nitrate; chlamydia and gonorrhea do not produce it. A first-void sample that is leukocyte esterase positive and nitrite negative is a classic, though not definitive, urethritis pattern.

Under the microscope, a technician counts white cells in the spun-down sediment. The CDC threshold of ten or more per high-power field in first-void urine is one of the accepted ways to confirm urethral inflammation.

Three limits deserve plain statement:

  • A negative dipstick does not rule out infection. Chlamydia in particular can be present with little visible inflammation, which is why the guidelines insist on a nucleic acid amplification test regardless of the dipstick result.
  • A midstream sample, which is what most urinalysis protocols request, dilutes the urethral signal. If a clinic runs a routine urinalysis without specifying first-catch, a borderline result may be falsely reassuring.
  • Urinalysis cannot distinguish gonorrhea from chlamydia from Mycoplasma genitalium, and those distinctions decide treatment.

So the practical answer to “Can urinalysis detect urethritis?” is that it can show the inflammation half of the diagnosis. The organism half needs a different test, and a good clinician orders both from the same cup.

Urethritis diagnosis tests compared: urinalysis, NAAT, Gram stain and culture

Four laboratory methods carry most of the weight. They answer different questions, run on different samples and return at different speeds, which is why a clinician may order more than one.

Doctor explaining urine test results to male patient: Urethritis diagnosis tests compared: urinalysis, NAAT, Gram stain and
Test Sample What it shows Main limitation
Urinalysis (dipstick and microscopy) First-void urine White cells; inflammation present or absent Cannot identify the organism
Nucleic acid amplification test (NAAT) First-catch urine or urethral, vaginal or cervical swab Genetic material of chlamydia, gonorrhea; also Mycoplasma genitalium and Trichomonas on request Does not report antibiotic susceptibility; result takes days
Gram stain Swab of urethral discharge White cells and, in gonorrhea, characteristic paired bacteria inside them, often within the visit Needs a microscope on site; less sensitive in women and in people without discharge
Culture Swab of discharge, or urine for bladder bacteria Grows living organisms; allows antibiotic susceptibility testing Slow; chlamydia culture rarely available; sensitive to transport delays

The CDC laboratory recommendations name NAAT as the preferred test for chlamydia and gonorrhea because of its sensitivity, which is substantially higher than culture or older antigen tests, and because a single urine sample serves both infections. Gram stain keeps its place in clinics with a microscope: in symptomatic men, seeing the paired bacteria inside white cells is specific enough that treatment for gonorrhea can begin the same day. Culture, slow as it is, remains the only way to test which antibiotics a gonorrhea strain still responds to, which is why the CDC asks for it when treatment seems to have failed.

No single row in that table is complete on its own. The combination is the diagnosis.

What are the common causes of urethral discharge in men?

Discharge from the urethra is a symptom, not a diagnosis, and the list of causes is longer than most people expect. Clinicians sort it into two broad groups.

Gonococcal urethritis is caused by Neisseria gonorrhoeae. It tends to produce a thicker, more obviously pus-like discharge and a sharper burning, often within two weeks of exposure, though the NHS notes that a share of infected men notice nothing at all.

Non-gonococcal urethritis, usually shortened to NGU, is everything else. According to the CDC treatment guidelines, Chlamydia trachomatis accounts for roughly 15 to 40 percent of NGU cases and Mycoplasma genitalium for about 15 to 25 percent. Trichomonas vaginalis, a parasite more often discussed in women, is a less common but real cause in men. Herpes simplex virus and adenovirus can inflame the urethra, typically alongside other symptoms such as sores or conjunctivitis. In a sizeable fraction of NGU, no organism is identified at all.

Non-infectious causes exist too. Irritation from a urinary catheter, vigorous sexual activity, certain spermicides or soaps, and, rarely, a narrowing of the urethra called a stricture can all mimic infection. The NHS lists these alongside the microbes precisely because they change what the clinician looks for.

Why does the distinction matter so much? Because the antibiotics differ. Gonorrhea is treated with a different class than chlamydia, Mycoplasma genitalium has its own resistance problems, and Trichomonas needs a drug that does nothing against the others. A urethritis diagnosis that stops at “discharge, probably infection” risks treating the wrong organism, which is why the guidelines push for organism-specific testing even when the symptoms look textbook.

Urethral discharge culture and swabs: when they are still used

Urine has made the swab less routine, yet there are moments when a swab is the better tool, and knowing why makes the procedure easier to accept.

A urethral swab is a thin, flexible stick with a small tip that is inserted a short distance, usually about a centimeter, into the opening of the urethra and rotated gently. MedlinePlus describes the sensation as brief discomfort or a stinging feeling; most people compare it to a sharp pinch that fades within seconds. If discharge is already visible at the tip, the swab may simply collect it without going inside.

Three situations keep the swab in use:

  • Same-day microscopy. A Gram stain needs cells smeared on a slide, which a swab provides and urine does not. In a clinic with a microscope, this is the fastest route to confirming inflammation and spotting gonorrhea.
  • Gonorrhea culture. The CDC recommends culture and antimicrobial susceptibility testing whenever gonorrhea persists after treatment, because resistance to several antibiotic classes is now documented worldwide. Culture requires living organisms on a specific transport medium, and a swab delivers them more reliably than urine.
  • Extra-urethral sites. Rectal and throat infections produce no urinary signal at all. For people whose sexual history makes those sites relevant, the CDC laboratory guidance supports NAAT on swabs from each site.

Culture has limits worth stating. Chlamydia culture is technically demanding and seldom available outside research settings. Gonorrhea culture loses sensitivity if the swab sits too long before reaching the lab. A negative culture therefore carries less reassurance than a negative NAAT, which is the reason guidelines treat NAAT as the primary diagnostic and culture as the susceptibility tool.

Urethritis vs UTI: how the workup tells them apart

Burning on urination is shared territory. A bladder infection and urethritis both cause it, and in the first minutes of an appointment they can look identical. The workup separates them along three lines.

The first is location of symptoms. Bladder infections, the common form of urinary tract infection or UTI, tend to bring urgency, frequency and a dull ache above the pubic bone, with burning throughout the stream. Urethritis more often stings at the start, may produce discharge, and in men is far more likely than a bladder infection, which is unusual in healthy younger men.

The second is the urine itself. Bladder bacteria are usually gut organisms that turn the nitrite pad positive and grow readily on a standard urine culture, which is the test the NIH’s kidney and urologic institute describes for confirming a bladder infection. Sexually transmitted organisms do neither. A urine that is cloudy with white cells but nitrite negative and culture negative points away from the bladder and toward the urethra.

The third is the sample type. A midstream specimen is correct for a bladder culture; a first-catch specimen is correct for urethral NAAT. When the clinician is genuinely unsure, both can be collected from one visit to the bathroom: first-catch into one cup, midstream into another.

The distinction is not academic. Antibiotics commonly used for bladder infections have little effect on chlamydia or gonorrhea. Someone treated for a presumed UTI who keeps burning a week later is a familiar story in sexual health clinics, and the usual missing step is the NAAT that was never ordered. In women, where bladder infections are common and urethritis is less visible, the CDC advises considering sexually transmitted causes whenever a UTI picture does not resolve as expected.

Who is usually tested right away, and who is usually asked to wait

Anyone with symptoms is tested at the first visit, full stop. Burning, discharge, or an itch at the urethral opening justify first-catch urine and, where available, a swab on the same day. Guidelines also support starting treatment before results return when inflammation is confirmed, so the waiting that follows is for the organism name, not for relief.

Partners of a person with a confirmed infection are tested and, under CDC guidance, usually treated at the same time regardless of their own result, because a negative test inside the window period cannot be trusted. The CDC asks that partners from the preceding 60 days be notified.

People without symptoms fall into two groups. Those with a known recent exposure are tested now and advised that a repeat after about two weeks, the interval the NHS cites for chlamydia, gives a more reliable answer. Those with no specific exposure but ongoing risk are offered routine screening: the CDC recommends annual chlamydia and gonorrhea screening for sexually active women under 25 and for men who have sex with men, at every site of exposure.

Being asked to wait usually means one of three things. The exposure was too recent for the test to turn positive. A course of antibiotics was finished within the past few weeks and could mask a culture. Or symptoms have already been treated appropriately and a test of cure is not indicated, in which case the CDC’s advice is a retest about three months later to catch reinfection rather than treatment failure.

Pregnancy changes the picture: a test of cure around four weeks after chlamydia treatment is recommended in pregnancy, because the stakes for the baby are higher. Your care team decides which category you fall into; none of these timings is a promise, only the interval at which evidence says a result is most trustworthy.

What results change: how the report steers treatment and follow-up

A urethritis result rarely arrives as a single word. It is a short set of lines, and each one moves the next decision.

Inflammation present, organism pending. This is the commonest same-day situation. CDC guidelines support treating empirically for non-gonococcal urethritis once inflammation is confirmed, with gonorrhea coverage added if the Gram stain or clinical picture suggests it. The first-line regimen for NGU in those guidelines belongs to the tetracycline class, generically doxycycline, chosen because it also covers Mycoplasma genitalium better than the older alternatives. Which agent, and for how long, is the prescriber’s call.

Gonorrhea positive. Treatment shifts to an injectable cephalosporin, generically ceftriaxone, because resistance has eroded nearly every oral option. The result also triggers partner notification for the preceding 60 days and a reminder to avoid sex until seven days after treatment and until partners are treated, both per CDC.

Chlamydia positive. The tetracycline-class course usually already covers it. A test of cure is not routinely recommended outside pregnancy; retesting at three months is.

Mycoplasma genitalium positive. Here the report may include macrolide resistance status, and the CDC describes a resistance-guided sequence of antibiotic classes. This is the result most likely to change a treatment that has already started.

Trichomonas positive. A nitroimidazole-class drug is used, which does nothing for the other organisms, so this finding alone can explain why an earlier course failed.

Everything negative, inflammation present. Treatment for NGU typically continues, and persistent symptoms prompt the additional tests described later.

What a result never does is tell you to stop, double or swap a medicine on your own. The report is read alongside symptoms, history and partner results, and the treating clinician makes that synthesis.

What the following days and weeks usually look like

The timeline after a urethritis visit is shorter than people fear and longer than people hope, in roughly equal measure.

Day one. Specimens are collected, and if inflammation is confirmed on the spot, treatment often begins before you leave. The CDC guidelines favor this approach because it shortens the infectious period and the discomfort.

Days one to ten. NAAT results come back. The NHS quotes a typical wait of around a week to ten days for chlamydia results in many services, while some laboratories return them within a couple of days. Gram stain results, where done, are available the same day; gonorrhea culture, if sent, takes several days to grow.

The first week of treatment. Burning and discharge usually ease within a few days of an antibiotic that matches the organism. The CDC asks for abstinence from sex until seven days after single-dose treatment or until a multi-day course is finished, and until partners have completed treatment too. Condoms during this week do not substitute for abstinence, because the aim is to prevent passing the infection back and forth.

Weeks two to four. Partners should have been tested and treated. Symptoms that are unchanged at this point, or that return after settling, are the signal for a follow-up visit rather than a second course of the same antibiotic.

About three months. The CDC recommends retesting everyone treated for chlamydia or gonorrhea around three months after treatment, not because the first course was doubted but because reinfection from an untreated partner is common. This is screening, not a test of cure.

None of these intervals is a guarantee of how any one person will feel. They are the typical ranges clinicians plan around.

Non-gonococcal urethritis test results that stay negative: persistent or recurrent urethritis

A fair number of people finish a course, feel better for a fortnight, and then notice the sting creeping back. Others never fully improve. Guidelines treat this as a distinct problem with its own checklist, and understanding it prevents a frustrating cycle of repeat prescriptions.

The first questions are not laboratory ones. Was the course completed? Was there sexual contact, including with the original partner, before both had finished treatment? Reinfection is the single most frequent explanation, and it has nothing to do with the antibiotic failing.

If adherence and re-exposure are excluded, the CDC’s persistent urethritis pathway adds tests that the first visit may not have included. A NAAT for Mycoplasma genitalium is the key one, ideally with macrolide resistance detection, because this organism is responsible for a large share of treatment-resistant NGU and does not respond reliably to the older antibiotic classes. A NAAT for Trichomonas vaginalis in men is the second, since it is missed by chlamydia and gonorrhea panels and treated with an unrelated drug. Where gonorrhea was the original diagnosis, culture with susceptibility testing is requested to detect a resistant strain.

Objective evidence of continuing inflammation matters here. The CDC advises confirming white cells on Gram stain or first-void urine before retreating, because persistent discomfort without inflammation points elsewhere: chronic pelvic pain syndromes, urethral irritation from frequent self-examination, or a stricture that a urologist may need to assess with a scope.

The NHS makes a related point about NGU: in a proportion of cases no cause is ever found, and symptoms can settle on their own over weeks. That is not a reason to skip investigation, but it is a reason not to assume that a negative panel means something has been missed. The treating team weighs the pattern, the test results and the exposure history together.

Women searching “how to heal an inflamed urethra” usually arrive after a cycle of burning, a presumed bladder infection, a short antibiotic course, and symptoms that drift back. The diagnostic logic for women shares its core with the male pathway but has three differences that matter.

The urethra in women is short, close to the vaginal opening, and easily irritated by things that are not infection at all: friction, spermicides, scented products, hormonal changes after menopause that thin the lining. MedlinePlus lists these irritant causes alongside the sexually transmitted ones. A history that fits irritation changes the first step from antibiotics to removing the trigger.

Infection, when present, is often in more than one place. Chlamydia and gonorrhea inflame the cervix as readily as the urethra, so the examination and the swab may be vaginal or cervical rather than urethral. The CDC laboratory guidance notes that a self-collected vaginal swab performs as well as a clinician-collected cervical swab for NAAT, and many services now offer it for comfort.

Bladder infection sits much higher on the list. A midstream urine for dipstick and culture is ordered alongside, or before, the first-catch NAAT, and the nitrite pad plus culture usually settles which one is responsible.

What this means for the question itself: there is no reliable way to settle an inflamed urethra without first learning why it is inflamed. Drinking adequate water and avoiding irritants are sensible while tests are pending, and the NHS advises against douching or scented washes, which worsen irritation. Antibiotics are the right tool only when a bacterial cause is confirmed or strongly suspected, and the choice depends on the organism. Persistent symptoms with negative tests deserve a conversation about non-infectious causes rather than another empirical course, and that conversation belongs with the treating clinician.

What people often get wrong about urethritis testing

Several beliefs circulate widely enough to cause real diagnostic errors. Each one has a specific correction in the evidence.

“Clear urine means I’m fine.” Chlamydia frequently causes little visible cloudiness, and NHS figures indicate that most infected people have no symptoms at all. Appearance is not a test.

“Any urine sample will do.” The CDC laboratory recommendations specify first-catch urine for NAAT. A midstream sample, the standard for bladder cultures, washes out the urethral cells before collection and can produce a falsely reassuring result.

“A negative dipstick rules out an STI.” The dipstick detects inflammation, not organisms. The guidelines require a NAAT regardless of dipstick findings for exactly this reason.

“I’d know if I had gonorrhea.” Men with urethral gonorrhea usually do notice discharge, but a minority do not, and throat and rectal infections are typically silent.

“Testing the next morning gives a definite answer.” It gives a baseline. The NHS window of about two weeks for chlamydia exists because the organism needs time to multiply to a detectable level.

“Leftover antibiotics from a friend will sort it.” Beyond the obvious risks, a partial course can suppress organisms enough to muddy a culture, delay a correct diagnosis and select for resistance, which is a documented problem for gonorrhea and Mycoplasma genitalium.

“The UTI test covered everything.” A standard urine culture is designed for gut bacteria and does not grow chlamydia, gonorrhea, Mycoplasma or Trichomonas. If an STI was not specifically requested, it was not looked for.

“If symptoms settle, the infection is gone.” Symptoms can wane while the organism persists, and reinfection from an untreated partner is common, which is why the CDC recommends retesting at about three months rather than relying on how you feel.

Questions to ask your care team

Most of the uncertainty after a urethritis visit comes from questions that were never asked in the room. These are the ones that tend to change what happens next, phrased so they can be put directly to the clinician or nurse.

  • Which tests were sent on my sample, and do they include chlamydia, gonorrhea, Mycoplasma genitalium and Trichomonas, or only the first two?
  • Was this a first-catch sample, and should I have held my urine beforehand? If the sample was collected the wrong way, is a repeat worth doing?
  • Do I need swabs from the throat or rectum based on my sexual history?
  • How long until results come back, and how will I be contacted if a result is positive?
  • If treatment is starting today, what is it covering, and will anything change once the organism is identified?
  • How long should my partner and I avoid sex, and does that apply even with condoms?
  • Which partners should be told, and can the clinic help with anonymous notification?
  • Is a test of cure needed in my situation, or is the three-month retest the plan?
  • If symptoms come back after treatment, should I return to this service or is a referral to urology or a sexual health specialist more appropriate?
  • Are there non-infectious explanations worth considering if all the tests return negative?

Write the answers down, or ask for them in the after-visit summary. A urethritis diagnosis is straightforward when the sequence of tests is clear; it becomes confusing only when a step is assumed rather than confirmed. Every decision about treatment, timing and follow-up rests with the team looking after you, and these questions simply make that conversation more precise.

When to call your doctor: red-flag signs

Uncomplicated urethritis is uncomfortable rather than dangerous. A small number of complications, however, need prompt assessment, and the warning signs are specific enough to recognize.

Seek care the same day, or urgently, if any of the following appear:

  • Pain, swelling or heat in one testicle or the scrotum. This can signal epididymitis, infection spreading to the tube behind the testicle, which the CDC treats as a distinct condition needing examination and sometimes imaging.
  • Fever or chills alongside urinary symptoms, which suggest infection has moved beyond the urethra.
  • Pain in the lower abdomen or pelvis in women, especially with fever or pain during sex, which can indicate pelvic inflammatory disease.
  • Inability to pass urine, or passing only small amounts with a feeling of blockage.
  • Pain in the flank or back with fever, which raises concern for a kidney infection rather than urethritis.
  • Joint pain, a new rash, or red painful eyes developing with or after urethral symptoms. These can accompany disseminated gonococcal infection or reactive arthritis and need a clinician’s assessment.
  • Visible blood in the urine that persists beyond the first day or two.

Contact the service that treated you, rather than waiting for the three-month retest, if symptoms have not improved within about a week of completing treatment, if they return after settling, or if a partner tests positive for an organism you were not treated for. Persistent symptoms do not mean the first course was wrong; they mean the next step in the guideline pathway is due.

Anyone who is pregnant, immunocompromised, or has a urinary catheter should have a lower threshold for calling, as should anyone whose symptoms began after a procedure on the urinary tract. In every case, the decision about further testing or a change of treatment belongs to the clinician who can examine you.

Frequently asked questions

What is the first-line treatment for urethritis?

It depends on the organism, which is why testing comes first. CDC guidelines list a tetracycline-class antibiotic, doxycycline, as first-line for non-gonococcal urethritis, and an injectable cephalosporin, ceftriaxone, for gonorrhea. Mycoplasma genitalium and Trichomonas each require different drugs. The choice, duration and any adjustments rest with the prescribing clinician once results are known.

What are the common causes of urethral discharge in men?

Gonorrhea and chlamydia are the two most frequent infectious causes, followed by Mycoplasma genitalium and, less often, Trichomonas, herpes simplex and adenovirus. Non-infectious irritation from catheters, spermicides or friction can also produce discharge. In a proportion of non-gonococcal cases no organism is ever identified, which is why organism-specific testing rather than symptom pattern decides treatment.

Can urinalysis detect urethritis?

It can detect the inflammation but not the cause. A positive leukocyte esterase pad or ten or more white cells per high-power field in first-void urine supports a urethritis diagnosis under CDC criteria. A negative result does not exclude infection, and the dipstick cannot distinguish chlamydia from gonorrhea, so a nucleic acid amplification test is always ordered alongside.

How to heal an inflamed urethra in a female?

The first step is finding out why it is inflamed, because treatment differs for bladder infection, sexually transmitted infection and simple irritation. Testing usually includes a midstream urine culture and a vaginal or first-catch NAAT. Avoiding scented products, spermicides and douching helps while results are pending. Antibiotics are appropriate only when a bacterial cause is confirmed, and the clinician selects the agent.

How long do urethritis urine test results take?

A Gram stain, where available, gives a same-day answer about inflammation and gonorrhea. Nucleic acid amplification tests for chlamydia and gonorrhea typically return within a few days to around ten days depending on the laboratory, the range the NHS quotes for chlamydia. Culture with susceptibility testing takes several days longer. Treatment often starts before results arrive.

Urethritis vs UTI: how can tests tell them apart?

A bladder infection usually turns the nitrite pad positive and grows gut bacteria on a standard midstream urine culture. Urethritis typically shows white cells with a negative nitrite and negative routine culture, and the organism appears only on a first-catch NAAT for sexually transmitted infections. Collecting both sample types from one visit lets the clinician sort the two.

What does a urethral discharge culture involve?

A thin swab collects discharge from the tip of the urethra or is inserted about a centimeter inside and rotated briefly, which stings for a few seconds. The sample is placed on a transport medium so gonorrhea can be grown and tested against antibiotics. Culture is slower and less sensitive than NAAT but is the only way to check antibiotic susceptibility.

What if my non-gonococcal urethritis test comes back negative but symptoms persist?

Persistent symptoms with a negative chlamydia and gonorrhea panel prompt additional tests under CDC guidance: a NAAT for Mycoplasma genitalium with resistance detection, a NAAT for Trichomonas in men, and confirmation that inflammation is still present. Reinfection and incomplete courses are checked first. Non-infectious causes, including urethral irritation and stricture, are considered when tests stay negative.

Do I need to hold my urine before a chlamydia test?

Modern nucleic acid amplification tests perform well on first-catch urine, and CDC laboratory guidance emphasizes catching the first part of the stream over a long gap since your last void. Many clinics still request about an hour without urinating to keep the sample concentrated. Follow your service’s instruction, and tell the clinician if you urinated shortly before the sample.

Does urethritis go away on its own?

Symptoms can fade without treatment, but that is not the same as the infection clearing. Chlamydia and gonorrhea often become silent while remaining transmissible and can lead to epididymitis or pelvic inflammatory disease. Some non-infectious or unexplained NGU does settle over weeks, as the NHS notes, but testing is still needed to identify which situation applies.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published November 18, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.